Back to results
UnknownPhase 1

Dual Integrin αvβ3 and GRPR Targeting PET Imaging in Breast Cancer Patients

NCT02749019

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College

Beijing, Beijing Municipality, China

Contact

Zhaohui Zhu, MD. PhD.

+86 10 69154196zhuzhh@pumch.cn
View on ClinicalTrials.gov
Dual Integrin αvβ3 and GRPR Targeting PET Imaging in Breast Cancer Patients — TrialFind